期刊文献+

国产药物洗脱支架在急性冠脉综合征介入治疗的应用

Application of Domestic Drug Eluting Excel Stent in the Intervention Treatment in Acute Coronary Syndrome
下载PDF
导出
摘要 目的评价Excel在ACSPCI中的安全性和有效性。方法87例ACS患者,其中ST段抬高性心肌梗死39例,非ST段抬高性心肌梗死22例,不稳定型心绞痛26例,在行PCI过程中置入国产药物洗脱支架—Excel支架。结果所有患者均成功地完成了PCI,共置入Excel支架132枚,随访期间无严重心脏不良事件发生,17例患者术后6个月复查冠状动脉造影,仅1例直径狭窄50%。结论国产药物洗脱支架可安全、有效地应用于ACS患者。 Objective To evaluate the safety and efficacy of domestic sirolimus-eluting Excel stent in the intervention of acute coronary syndrome (ACS). Methods 87 patients with ACS,of which 39 patients had STEMI,22 patients had NSTEMI and 26 patients had unstable angina COA), had been treated with Excel stents. Results 87 patients were successfully treated by percutaneous coronary intervention(PCI),total 132 Excel stents were implanted.At follow-up after operations, no severe adverse cardiac events happened, only one patient appeared instent restenosis 50% in 17 patients who received coronary angiography(CAG) in six months after PCI. Conclusion Implanting of domestic sirohmuseluting Excel stent might be safe and effective in patients with ACS.
出处 《中国现代医生》 2007年第09X期83-84,共2页 China Modern Doctor
关键词 急性冠脉综合征 支架 西罗莫司 Acute coronary syndrome Stent Sirolimus
  • 相关文献

参考文献1

二级参考文献11

  • 1Allm jM, Brett SL, Jonathan BG, et al. Stent thrombosis after successful sirolimus-eluting strut implantation. Circulation, 2004,109:1930-1932. 被引量:1
  • 2Pedro A, Lee CH, Francesco S, et al. Early outcome after sirolimus eluting stem implantation in patients with acute coronary syndromes. J Am Coll Cardiol, 2003,41:2093-2099. 被引量:1
  • 3Braunwald E. Unstable angina: A classification. Circulation, 1989,80:410. 被引量:1
  • 4Gallo R, Padu A, Chesebro JH, et al. Inhibition of intimal thickening after balloon angioplasty in porcine coronary arteries by rapamycin. Ciretdafion, 1998,99:2164-2170. 被引量:1
  • 5Stevea O, Andrew R. The development of rapamycin and its application to steat restenosis. Circulation, 2001,104 : 852-855. 被引量:1
  • 6Morice MC, Sermys PW, Sousa JE, et al. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. The REVEL trial. N Engl J Med, 2002,346:1773-1780. 被引量:1
  • 7Patrick W, Muzaffer D, Kengo T, et al. Intravascular ultrasound findings in the multicenter, randomized, double-blind RAVEL trial.Circulation, 2002,106:798-803. 被引量:1
  • 8Sousa JE, Costa MA, Abizaid AC, et al. Sustained suppression of neointimal proliferation by sirolimus-duting stent. Circulation, 2001,104:2007-2011. 被引量:1
  • 9Sousa JE, Sermys PW, Costa MA. New frontiers in cardiology: drugeluting steat, part Ⅰ. Circulation, 2003,107:2274-.2279. 被引量:1
  • 10Sousa JE, Serruys PW, Costa MA. New frontiers in cardiology: drugeluting stent. part Ⅱ. Circulation, 2003,107:2383-2389. 被引量:1

共引文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部